When Gary Schwitzer talks at a health care journalists congress the result is the below brilliant course of medical research methodology.
The way health care journalists report the lowering of risk linked to a medical or pharmaceutical intervention has an impact on the size of the interest the public will give to the so-called innovative therapy. The example chosen by Gary with Nolvadex and breast cancer risk is very striking (see slide 36).
Thank you Gary Schwitzer for this very informative lecture which benefits not only to journalists but also to health care consumers (i.e. all of us).
- Well: How Doctors and Patients Do Harm (well.blogs.nytimes.com)